Cancer prevention and control: Kaposi's sarcoma.
Cancer prevention and control: Kaposi's sarcoma.
Ecancermedicalscience. 2019;13:951
Authors: Orem J
Abstract
Kaposi's sarcoma (KS) is a vascular tumour of endothelial origin that is associated with human herpes virus-8 infection. In sub-Saharan Africa, AIDS-KS remains the most common HIV-associated malignancy, and hence it poses a huge burden to the already constrained health-care systems. KS has four clinical variants, namely, classic, endemic, iatrogenic and epidemic KS. The histopathology in these different KS forms is essentially identical; however, they have different clinical patterns. Expanding knowledge of KS biology increases hope for prevention, disease control, and hence better quality of life among patients. Primary prevention strategy for KS-associated herpes virus and management of disease complication, such as lymphoedema should be the focus of disease-prevention and -control research.
PMID: 31552124 [PubMed]
Source: Ecancermedicalscience - Category: Cancer & Oncology Tags: Ecancermedicalscience Source Type: research
More News: African Health | Biology | Cancer | Cancer & Oncology | Endemics | Epidemics | Epidemiology | Health Management | Herpes | HIV AIDS | Lymphedema | Sarcomas